Literature DB >> 6971258

Interaction of Pneumocystis carinii with host lungs: an ultrastructural study.

K Yoneda, P D Walzer.   

Abstract

Pneumocystis carinii pneumonia was produced in rats by the administration of corticosteroids, low (8%) protein diet, and tetracycline in the drinking water. The rats were sacrificed at weekly intervals, and their lungs were examined by electron microscopy. For the first 6 weeks, few alterations were noted in host pulmonary tissue, except a close attachment of P. carinii trophozoites to the type I pneumocytes. At 7 to 8 weeks, when the infection reached the peak intensity on light microscopy, degenerative changes occurred in the type I pneumocyte, beginning with subepithelial bleb formation and followed by denudation of the basement membrane. This denuded surface appeared to be the site both of exudation of serum and tissue fluid into the alveolar space and of spread of P. carinii into the interstitium. There was hypertrophy of type II pneumocytes, which also occurred in uninfected control rats ingesting tetracyclines. With tapering of the corticosteroid dose, P. carinii was slowly cleared from the lungs, but latent infection persisted for at least 21 weeks. The host response to the corticosteroid dose tapering included increased prominence of alveolar macrophages and progressive interstitial lymphocytic infiltrate and fibrosis. Thus, P. carinii interacts with, and is associated with damage to, specific host cells. This interaction is important in the host-parasite relationship in this infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6971258      PMCID: PMC551182          DOI: 10.1128/iai.29.2.692-703.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Pneumocystis carinii: new separation method from lung tissue.

Authors:  P D Walzer; M E Rutledge; K Yoneda; B J Stahr
Journal:  Exp Parasitol       Date:  1979-06       Impact factor: 2.011

2.  Mechanism of exudation through intact alveolar epithelial cells in the lungs of cytomegalovirus-infected mice.

Authors:  A R Brody; P C Kelleher; J E Craighead
Journal:  Lab Invest       Date:  1978-09       Impact factor: 5.662

3.  Developmental biology of Pneumocystis carinii, and alternative view on the life cycle of the parasite.

Authors:  M E Vossen; P J Beckers; J H Meuwissen; A M Stadhouders
Journal:  Z Parasitenkd       Date:  1978-04-20

4.  Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features.

Authors:  P D Walzer; D P Perl; D J Krogstad; P G Rawson; M G Schultz
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

5.  Ultrastructure of Pneumocystis in human lung. Life cycle in human pneumocystosis.

Authors:  W G Campbell
Journal:  Arch Pathol       Date:  1972-04

6.  Pneumocystis carinii delanoë, its ultrastructure and ultrastructural affinities.

Authors:  J Vavra; K Kucera
Journal:  J Protozool       Date:  1970-08

7.  Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; R D Powell; K Yoneda; M E Rutledge; J E Milder
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

8.  Protein-calorie malnutrition. A host determinant for Pneumocystis carinii infection.

Authors:  W T Hughes; R A Price; F Sisko; W S Havron; A G Kafatos; M Schonland; P M Smythe
Journal:  Am J Dis Child       Date:  1974-07

Review 9.  Are viruses important in carcinogenesis?

Authors:  F Rapp; E R Buss
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

10.  The interaction in vitro of Pneumocystis carinii with macrophages and L-cells.

Authors:  H Masur; T C Jones
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Pneumocystis.

Authors:  Francis Gigliotti; Andrew H Limper; Terry Wright
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  High osmotic pressure enables fine ultrastructural and cytochemical studies on Pneumocystis carinii. I. Epon embedding.

Authors:  F Palluault; C Slomianny; B Soulez; E Dei-Cas; D Camus
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

3.  Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells.

Authors:  Jing Wang; Francis Gigliotti; Sanjay Maggirwar; Carl Johnston; Jacob N Finkelstein; Terry W Wright
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice.

Authors:  Steve D Swain; Terry W Wright; Peter M Degel; Francis Gigliotti; Allen G Harmsen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Pneumocystis carinii: oxygen uptake, antioxidant enzymes, and susceptibility to oxygen-mediated damage.

Authors:  E L Pesanti
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

6.  Mechanism of pulmonary alveolar injury in experimental Pneumocystis carinii pneumonia in the rat.

Authors:  K Yoneda; P D Walzer
Journal:  Br J Exp Pathol       Date:  1981-08

7.  Diagnostic value of lung clearance of 99mTc DTPA compared with other non-invasive investigations in Pneumocystis carinii pneumonia in AIDS.

Authors:  D S Robinson; D A Cunningham; S Dave; J Fleming; D M Mitchell
Journal:  Thorax       Date:  1991-10       Impact factor: 9.139

8.  Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia.

Authors:  S Kernbaum; J Masliah; L G Alcindor; C Bouton; D Christol
Journal:  Br J Exp Pathol       Date:  1983-02

9.  Growth and serial passage of Pneumocystis carinii in the A549 cell line.

Authors:  M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

10.  Attachment of Pneumocystis carinii to type I alveolar cells studied by freeze-fracture electron microscopy.

Authors:  K Yoneda; P D Walzer
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.